Inactive Instrument
RAMM Pharma Corp. Stock OTC Markets
Stocks
RAMMF
CA75150G1046
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.19M 844K 739K 681K 629K 80.53M 1.21M 8.14M 3.2M 39.67M 3.17M 3.1M 136M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 333K 291K 268K 248K 31.73M 478K 3.21M 1.26M 15.63M 1.25M 1.22M 53.74M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -76.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -76.29% | -92.33% | - | - | 844K | ||
| -2.33% | -2.09% | +49.88% | +169.76% | 1,060B | ||
| -0.82% | -2.30% | +63.79% | +62.56% | 619B | ||
| -0.73% | -4.98% | +28.91% | +83.79% | 438B | ||
| +0.33% | -1.17% | +31.07% | +26.57% | 333B | ||
| -0.02% | -2.85% | +29.15% | +46.14% | 282B | ||
| -3.89% | -11.22% | +22.81% | +25.23% | 267B | ||
| +0.66% | -1.42% | -26.59% | -37.67% | 218B | ||
| -0.06% | -2.88% | +23.07% | +61.02% | 196B | ||
| -3.72% | -1.10% | +18.41% | +69.98% | 161B | ||
| Average | -8.69% | -3.33% | +26.72% | +56.38% | 397.1B | |
| Weighted average by Cap. | -1.31% | -3.10% | +36.75% | +83.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.07M 2.69M 2.48M 2.29M 293M 4.42M 29.6M 11.63M 144M 11.53M 11.28M 496M | 3.36M 2.38M 2.08M 1.92M 1.77M 227M 3.42M 22.91M 9M 112M 8.92M 8.73M 384M |
| Net income | -16.5M -11.67M -10.21M -9.42M -8.7M -1.11B -16.78M -113M -44.18M -548M -43.82M -42.87M -1.89B | -8.91M -6.3M -5.51M -5.08M -4.7M -601M -9.06M -60.75M -23.86M -296M -23.66M -23.15M -1.02B |
| Net Debt | -626K -443K -387K -357K -330K -42.21M -636K -4.27M -1.68M -20.79M -1.66M -1.63M -71.48M | -723K -512K -448K -413K -381K -48.8M -736K -4.93M -1.94M -24.04M -1.92M -1.88M -82.65M |
Employees
-
Sector
Pharmaceuticals
















